Your browser doesn't support javascript.
loading
Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Efficacy, and Biomarkers.
Wang, Yakun; Liu, Tianshu; Chen, Gongyan; Gong, Jifang; Bai, Yuxian; Zhang, Tao; Xu, Nong; Liu, Li; Xu, Jianming; He, Jianxing; Liu, Yunpeng; Zhang, Li; Jiang, Da; Wang, Mengzhao; Chang, Jianhua; Li, Wei; Bai, Chunmei; Zhou, Jinghong; Wang, Jian; Ren, Yongxin; Zhang, Liya; Su, Weiguo; Liu, Baorui; Shen, Lin.
Afiliación
  • Wang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Early Drug Development Center, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Liu T; Department of Medical Oncology, Zhongshan Hospital, and Center of Evidence-Based Medicine, Fudan University, Shanghai, People's Republic of China.
  • Chen G; Department of Respiratory Medicine, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
  • Gong J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology/Early Drug Development Center, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Bai Y; Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
  • Zhang T; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Xu N; Department of Medical Oncology, The First Affiliated Hospital of Zhejiang University, Hangzhou, People's Republic of China.
  • Liu L; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Xu J; Department of Gastrointestinal Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China.
  • He J; Department of Thoracic Surgery/Oncology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
  • Liu Y; State Key Laboratory and National Clinical Research Center for Respiratory Disease, Guangzhou, People's Republic of China.
  • Zhang L; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, People's Republic of China.
  • Jiang D; State Key Laboratory of Oncology in South China, Guangzhou, People's Republic of China.
  • Wang M; Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Chang J; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Li W; Department of Medical Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Bai C; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Zhou J; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
  • Wang J; Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen, People's Republic of China.
  • Ren Y; Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
  • Zhang L; Department of Medical Oncology, Chinese Academy of Medical Science, Peking Union Medical College Hospital, Beijing, People's Republic of China.
  • Su W; Hutchison China MediTech Limited, Shanghai, People's Republic of China.
  • Liu B; Hutchison China MediTech Limited, Shanghai, People's Republic of China.
  • Shen L; Hutchison China MediTech Limited, Shanghai, People's Republic of China.
Oncologist ; 2022 Apr 21.
Article en En | MEDLINE | ID: mdl-35445725
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article